Squamous cell carcinoma of skin of eyelid, including canthus
ICD-10 C44.12 is a billable code used to indicate a diagnosis of squamous cell carcinoma of skin of eyelid, including canthus.
Squamous cell carcinoma (SCC) of the skin of the eyelid, including the canthus, is a malignant neoplasm that arises from the squamous cells of the epidermis. This type of skin cancer is often associated with prolonged sun exposure, particularly in fair-skinned individuals. The eyelid is a common site for skin cancers due to its exposure to ultraviolet (UV) radiation. SCC can present as a persistent, non-healing sore, a scaly patch, or a raised growth that may bleed or crust. Diagnosis typically involves a biopsy to confirm the presence of malignant cells. Treatment options may include surgical excision, Mohs micrographic surgery, or radiation therapy, depending on the tumor's size, location, and depth of invasion. Surgical margins are critical in ensuring complete removal of the cancerous tissue, and reconstruction may be necessary to restore the eyelid's appearance and function post-excision. Given the delicate nature of eyelid anatomy, careful planning and execution of reconstructive techniques are essential to minimize functional impairment and cosmetic defects.
Detailed descriptions of the lesion, biopsy results, and treatment plans.
Diagnosis and treatment of skin cancers, including SCC and basal cell carcinoma.
Ensure accurate documentation of margins and reconstruction techniques.
Comprehensive surgical notes detailing excision and reconstruction methods.
Reconstruction of eyelid defects post-excision of skin cancers.
Focus on functional outcomes and aesthetic results in documentation.
Used for excision of SCC on eyelid with reconstruction.
Detailed operative report including margins and reconstruction.
Ensure documentation reflects the complexity of eyelid anatomy.
The primary treatment for squamous cell carcinoma of the eyelid is surgical excision, often followed by reconstruction to restore eyelid function and appearance.